個別化医療とバイオインフォマティックス

Saved in:
Bibliographic Details
Published in生体医工学 Vol. 44; no. 3; pp. 422 - 427
Main Author 鎌谷, 直之
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本生体医工学会 2006
Online AccessGet full text
ISSN1347-443X
1881-4379
DOI10.11239/jsmbe.44.422

Cover

Author 鎌谷, 直之
Author_xml – sequence: 1
  fullname: 鎌谷, 直之
  organization: 東京女子医科大学膠原病リウマチ痛風センター 東京女子医科大学大学院先端生命医科学系専攻遺伝子医学分野
BookMark eNo9jz1LAzEcxoNUsNaOfow7k_xzuWQsxTcouCi4Hbk00TvaKndd3DQBEezgouDiooK6ODiJHyccfg3fisvveeAHDzzLqDU5mhiEVgmOCaEg18p6nJuYsZhRuoDaRAgSMUhl67sDSyPGYH8Jdeu6yDEmBGNMkzaSzellc_HYzG6a2cfnrQtnT8FfBfcQ3MsP_Vvw18E9B38X_Hlw98H74F6De19Bi1aNatOdZwftbazv9reiwc7mdr83iEqKOY8AA5OCA9ZM2hSAczukAg-l0qBkntgh1yo3kFrMmTAWhNWJllZJKY2QGDqo97db1lN1YLLjqhir6iRT1bTQI5P9_s4Yy2AOSv-dPlRVVir4AnwxaIo
ContentType Journal Article
Copyright 2006 社団法人日本生体医工学会
Copyright_xml – notice: 2006 社団法人日本生体医工学会
DOI 10.11239/jsmbe.44.422
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1881-4379
EndPage 427
ExternalDocumentID article_jsmbe_44_3_44_3_422_article_char_ja
GroupedDBID 2WC
ALMA_UNASSIGNED_HOLDINGS
JSF
OK1
RJT
ID FETCH-LOGICAL-j2066-303498630c49f73366fd280d9ac3a9b5fd6cabe37f0648ef38fc5c9fa999e8903
ISSN 1347-443X
IngestDate Wed Sep 03 06:10:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2066-303498630c49f73366fd280d9ac3a9b5fd6cabe37f0648ef38fc5c9fa999e8903
OpenAccessLink https://www.jstage.jst.go.jp/article/jsmbe/44/3/44_3_422/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_jsmbe_44_3_44_3_422_article_char_ja
PublicationCentury 2000
PublicationDate 2006
PublicationDateYYYYMMDD 2006-01-01
PublicationDate_xml – year: 2006
  text: 2006
PublicationDecade 2000
PublicationTitle 生体医工学
PublicationTitleAlternate 生体医工学
PublicationYear 2006
Publisher 公益社団法人 日本生体医工学会
Publisher_xml – name: 公益社団法人 日本生体医工学会
References 10. Iwamoto T, Ikari K, Nakamura T, Kuwahara M, Toyama Y, Tomatsu T, Momohara S, Kamatani N: Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology. 45: 804-807, 2006.
11. Benjamini and Y Hochberg: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. Roy Stat Soc, Ser B. 57: 289-300, 1995.
18. Kamatani N, Sekine A, Kitamoto T, Iida A, Saito S, Kogame A, Inoue E, Kawamoto M, Harigai M, Nakamura Y: Large-scale single-nucleotide polymorphism(SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysisof the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet. 75: 190-203, 2004.
24. Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, Kluve-Beckerman B: An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid. 10(1): 7-11, 2003.
3. Evans DAP, Manley K, McKusick VA: Genetic control of isoniazid metabolism in man. Br Med J. 5197: 485-491, 1960.
4. Vessel ES, Page JG: Genetic control of drug levels in man: phenylbutazone. Science. 159(822): 1479-1480, 1968.
7. International HapMap Consortium: Integrating ethics and science in the International HapMap Project. Nat Rev Genet. 5: 467, 2004.
21. Tanaka E, Taniguchi A, Urano W, Nakajima H, Matsuda Y, Kitamura Y, Saito M, Yamanaka H, Saito T, Kamatani N: Adverse effects of sulphasalazine in rheumatoid arthritis patients are associated with diplotype configuration at N-actyltransferase 2 gene. J Rheumatol. 29: 2492-2499, 2002.
15. Ito T, Chiku S, Inoue E, Tomita M, Morisaki T, Morisaki H, Kamatani N: Estimation of haplotype frequencies, linkage disequilibrium measures and combination of haplotype copies in each pool using pooled DNA data. Am J Hum Genet. 72: 384-398, 2003.
1. Beutler E, Mathai CK, Smith JE: Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood. 31(2): 131-150, 1968.
22. Van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB: The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum. 44(11): 2525-2530, 2001.
8. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 279: 1200-1205, 1998.
6. Vesell ES: Advances in pharmacogenetics. Prog Med Genet. 9: 291-367, 1973.
23. Schmeling H, Biber D, Heins S, Horneff G: Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol. 32(9): 1832-1836, 2005.
5. Vessel ES, Page JG: Genetic control of drug levels in man: antipyrine. Science. 161(836): 72-73, 1968.
17. Shibata K, Ito T, Kitamura Y, Iwasaki N, Tanaka H, Kamatani N: Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration. Genetics 168: 525-539, 2004.
19. Taniguchi A, Urano W, Tanaka E, Furihata S, Kamitsuji S, Inoue E, Yamanaka M, Yamanaka H, Kamatani N: Validation of the associations between SNPs or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: aproposal for prospective pharmacogenomic study in clinical practice. Pharmacogenet Genomics in press
2. Lehmann H, Ryan E: The familial incidence of low pseudocholinesterase level. Lancet. 271(6934): 124, 1956.
12. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen CL, Kamatani N: Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet. 105(4): 360-366, 1999.
20. Urano W, Taniguchi A, Yamanaka H, Tanaka E, Nakajima H, Matsuda Y, Akama H, Kitamura Y, Kamatani N: Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics. 12: 183-190, 2002.
9. Takitoh S, Fujii S, Mase Y, Takasaki J, Yamazaki S, Ohnishi Y, Yanagisawa M, Nakamura Y: Accurate automated clustering of two-dimensional data for single-nucleotide polymorphism genotyping by a combination of clustering methods: evaluation by large-scale real data. Bioinformatics in press
16. Ito T, Inoue E, Kamatani N: Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances. Genetics 168: 2339-2348, 2004.
13. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N: A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum. 44(6): 1266-1272, 2001.
14. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N: Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet. 66: 183-193, 2002.
References_xml – reference: 8. Lazarou J, Pomeranz BH, Corey PN: Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 279: 1200-1205, 1998.
– reference: 12. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen CL, Kamatani N: Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet. 105(4): 360-366, 1999.
– reference: 18. Kamatani N, Sekine A, Kitamoto T, Iida A, Saito S, Kogame A, Inoue E, Kawamoto M, Harigai M, Nakamura Y: Large-scale single-nucleotide polymorphism(SNP) and haplotype analyses, using dense SNP Maps, of 199 drug-related genes in 752 subjects: the analysisof the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am J Hum Genet. 75: 190-203, 2004.
– reference: 15. Ito T, Chiku S, Inoue E, Tomita M, Morisaki T, Morisaki H, Kamatani N: Estimation of haplotype frequencies, linkage disequilibrium measures and combination of haplotype copies in each pool using pooled DNA data. Am J Hum Genet. 72: 384-398, 2003.
– reference: 21. Tanaka E, Taniguchi A, Urano W, Nakajima H, Matsuda Y, Kitamura Y, Saito M, Yamanaka H, Saito T, Kamatani N: Adverse effects of sulphasalazine in rheumatoid arthritis patients are associated with diplotype configuration at N-actyltransferase 2 gene. J Rheumatol. 29: 2492-2499, 2002.
– reference: 17. Shibata K, Ito T, Kitamura Y, Iwasaki N, Tanaka H, Kamatani N: Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration. Genetics 168: 525-539, 2004.
– reference: 20. Urano W, Taniguchi A, Yamanaka H, Tanaka E, Nakajima H, Matsuda Y, Akama H, Kitamura Y, Kamatani N: Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics. 12: 183-190, 2002.
– reference: 24. Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, Kluve-Beckerman B: An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid. 10(1): 7-11, 2003.
– reference: 19. Taniguchi A, Urano W, Tanaka E, Furihata S, Kamitsuji S, Inoue E, Yamanaka M, Yamanaka H, Kamatani N: Validation of the associations between SNPs or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: aproposal for prospective pharmacogenomic study in clinical practice. Pharmacogenet Genomics in press
– reference: 2. Lehmann H, Ryan E: The familial incidence of low pseudocholinesterase level. Lancet. 271(6934): 124, 1956.
– reference: 1. Beutler E, Mathai CK, Smith JE: Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease. Blood. 31(2): 131-150, 1968.
– reference: 11. Benjamini and Y Hochberg: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. Roy Stat Soc, Ser B. 57: 289-300, 1995.
– reference: 9. Takitoh S, Fujii S, Mase Y, Takasaki J, Yamazaki S, Ohnishi Y, Yanagisawa M, Nakamura Y: Accurate automated clustering of two-dimensional data for single-nucleotide polymorphism genotyping by a combination of clustering methods: evaluation by large-scale real data. Bioinformatics in press
– reference: 7. International HapMap Consortium: Integrating ethics and science in the International HapMap Project. Nat Rev Genet. 5: 467, 2004.
– reference: 4. Vessel ES, Page JG: Genetic control of drug levels in man: phenylbutazone. Science. 159(822): 1479-1480, 1968.
– reference: 22. Van Ede AE, Laan RF, Blom HJ, Huizinga TW, Haagsma CJ, Giesendorf BA, de Boo TM, van de Putte LB: The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis Rheum. 44(11): 2525-2530, 2001.
– reference: 14. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N: Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet. 66: 183-193, 2002.
– reference: 10. Iwamoto T, Ikari K, Nakamura T, Kuwahara M, Toyama Y, Tomatsu T, Momohara S, Kamatani N: Association between PADI4 and rheumatoid arthritis: a meta-analysis. Rheumatology. 45: 804-807, 2006.
– reference: 13. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N: A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum. 44(6): 1266-1272, 2001.
– reference: 5. Vessel ES, Page JG: Genetic control of drug levels in man: antipyrine. Science. 161(836): 72-73, 1968.
– reference: 3. Evans DAP, Manley K, McKusick VA: Genetic control of isoniazid metabolism in man. Br Med J. 5197: 485-491, 1960.
– reference: 16. Ito T, Inoue E, Kamatani N: Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances. Genetics 168: 2339-2348, 2004.
– reference: 23. Schmeling H, Biber D, Heins S, Horneff G: Influence of methylenetetrahydrofolate reductase polymorphisms on efficacy and toxicity of methotrexate in patients with juvenile idiopathic arthritis. J Rheumatol. 32(9): 1832-1836, 2005.
– reference: 6. Vesell ES: Advances in pharmacogenetics. Prog Med Genet. 9: 291-367, 1973.
SSID ssib001100025
ssib002484549
ssib023159591
ssj0069534
ssib020474828
ssib000937326
ssib058494337
ssib002223871
ssib046007037
ssib007484362
Score 1.6682217
SourceID jstage
SourceType Publisher
StartPage 422
Title 個別化医療とバイオインフォマティックス
URI https://www.jstage.jst.go.jp/article/jsmbe/44/3/44_3_422/_article/-char/ja
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 生体医工学, 2006, Vol.44(3), pp.422-427
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Ni9QwFA_retGD-Inf7MGcpGPbpG0iXtrZLouiIOzC3ko_DwOuorMXT9qCCO7Bi4IXLyqoFw-exD8nDP4bvpc2Mxn0sKswhMfLSyavL9P8XibvhZBrsijCGk_PVEHNHe6J0ik8UWGsjPAaL2eFxODku_fCzW1-eyfYWTlyyzq1tDctRuXTv8aV_ItVgQd2xSjZQ1h23ikwgAb7QgkWhvJANqZpgCcVRKIJQeNAE2Mqw4FIoCqiUlLh05QBbKSx0ASj0tWET2NuiHiZw2jCjHBgqqThpAMhQlNlhAUznI2BSKQNgvWQOJVQy2myTiWzRhvQJBoUiddpPN84pCkokaJUKmjiohTMDt1VQhOuuwKJZHkbYz7l9DdAl-OhhYiRAEWTFKuAg8MPUWPUFfgxfK4jS_bjAWJs2h908FoGzBFb737GI4dzfT0xLI09TwhwsVl_341ZMPqElcMPg1lvf96HWA9AgvdJD_5co3yGOV4nTx4U9Yjz0bzVUtrvYVJlWizjPGND4fuZqcPAvGwC3sFRP4o8PNB6574FrgF52uAckwPa_ykjMhSRHdUsuP2fL2aZZYtkkr7LgbNwVsExCKSV_JDjTQfuAuwCspWcLbY_Qhn0ZzzMYzYZb-Fx3LAfBmDBCXhG5lSlBnpbJ8mJwUNbi3vtT5GVSX6aHLfydp4hcvbs1ezlp9n-29n-z1_vWvX8s-peq_ajar9i2X1X3RvVflHde9W9UO0H1XWq_abaH2fJ9ka6Nd50hjtInAledOAwzN8kQuaWXDaYOjRsKl-4lcxLlssiaKqwzIuaRQ1ge1E3TDRlUMomB8erFtJl58jq7sPd-jxZK5uggBWv9kKOOa1qCTCpgG6rKM-j0uMXyM1e7-xRn2gmO8QcuPg_jS-RY4udxctkdfp4r74CWHtaXNVT6jez3aeF
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%80%8B%E5%88%A5%E5%8C%96%E5%8C%BB%E7%99%82%E3%81%A8%E3%83%90%E3%82%A4%E3%82%AA%E3%82%A4%E3%83%B3%E3%83%95%E3%82%A9%E3%83%9E%E3%83%86%E3%82%A3%E3%83%83%E3%82%AF%E3%82%B9&rft.jtitle=%E7%94%9F%E4%BD%93%E5%8C%BB%E5%B7%A5%E5%AD%A6&rft.au=%E9%8E%8C%E8%B0%B7%2C+%E7%9B%B4%E4%B9%8B&rft.date=2006&rft.pub=%E5%85%AC%E7%9B%8A%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E7%94%9F%E4%BD%93%E5%8C%BB%E5%B7%A5%E5%AD%A6%E4%BC%9A&rft.issn=1347-443X&rft.eissn=1881-4379&rft.volume=44&rft.issue=3&rft.spage=422&rft.epage=427&rft_id=info:doi/10.11239%2Fjsmbe.44.422&rft.externalDocID=article_jsmbe_44_3_44_3_422_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1347-443X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1347-443X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1347-443X&client=summon